首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1584555篇
  免费   112475篇
  国内免费   4869篇
耳鼻咽喉   23618篇
儿科学   46354篇
妇产科学   45677篇
基础医学   222618篇
口腔科学   47952篇
临床医学   133927篇
内科学   312237篇
皮肤病学   35769篇
神经病学   124639篇
特种医学   62313篇
外国民族医学   508篇
外科学   247042篇
综合类   37985篇
现状与发展   6篇
一般理论   491篇
预防医学   104518篇
眼科学   38615篇
药学   120156篇
  5篇
中国医学   4444篇
肿瘤学   93025篇
  2018年   14866篇
  2016年   12969篇
  2015年   14567篇
  2014年   20582篇
  2013年   30488篇
  2012年   40009篇
  2011年   42127篇
  2010年   25129篇
  2009年   24372篇
  2008年   40145篇
  2007年   43896篇
  2006年   44217篇
  2005年   42434篇
  2004年   41106篇
  2003年   39811篇
  2002年   39136篇
  2001年   80151篇
  2000年   82205篇
  1999年   69457篇
  1998年   18144篇
  1997年   16332篇
  1996年   15486篇
  1995年   14568篇
  1994年   13549篇
  1992年   52960篇
  1991年   50507篇
  1990年   49502篇
  1989年   48292篇
  1988年   44875篇
  1987年   44058篇
  1986年   41877篇
  1985年   39795篇
  1984年   29393篇
  1983年   24831篇
  1982年   14570篇
  1981年   13106篇
  1979年   27809篇
  1978年   19478篇
  1977年   16993篇
  1976年   15079篇
  1975年   17245篇
  1974年   20346篇
  1973年   19753篇
  1972年   18958篇
  1971年   17827篇
  1970年   16795篇
  1969年   16238篇
  1968年   15155篇
  1967年   13472篇
  1966年   12590篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
45.
46.
47.
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V 1), peripheral volume (V 2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V 1, V 2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V 1 and V 2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit.  相似文献   
48.
49.
INTRODUCTIONPsoriasis is a chronic inflammatory condition that affects the skin and joints, and is associated with cardiovascular risk factors, including metabolic syndrome (MetS). We aimed to assess the prevalence of MetS in patients with psoriasis and determine whether there was a correlation between psoriasis severity and MetS in a Singapore population.METHODSThis was a cross-sectional study of patients with psoriasis, aged 18–69 years, who attended a tertiary dermatology referral centre in Singapore from October 2007 to February 2009. Fasting glucose, lipids, blood pressure, Psoriasis Area and Severity Index, and body mass index were measured. MetS was diagnosed in the presence of three or more criteria of the modified National Cholesterol Education Program Adult Treatment Panel III.RESULTSAmong 338 patients with psoriasis, there were 238 (70.4%) men and 100 (29.6%) women, who were Chinese (n = 228; 67.5%), Malay (n = 52; 15.4%) and Indian (n = 58; 17.2%). The prevalence of MetS was 45.1%. MetS was 44% more prevalent in patients older than 50 years (p = 0.02). Malay patients with psoriasis were significantly more likely to have hypertriglyceridaemia, elevated fasting plasma glucose and abdominal obesity. There was no significant correlation between psoriasis severity and risk of MetS.CONCLUSIONThe prevalence of MetS in patients with psoriasis in Singapore was 45.1%, or nearly threefold higher than the Singapore general population. Patients with psoriasis should be screened yearly for MetS and any modifiable cardiovascular risk factors should be actively controlled.  相似文献   
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号